Sponsor hub
European Organisation for Research and Treatment of Cancer - EORTC clinical trial failures
Review 36 stopped clinical trials from European Organisation for Research and Treatment of Cancer - EORTC, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 20
- OTHER/UNKNOWN
- 13
- SAFETY
- 3
Notable sponsors
- European Organisation for Research and Treatment of Cancer - EORTC
- 36
Related phases
- Phase II
- 26
- Phase III
- 10
Crawlable stopped-trial records
Open ExploreShowing up to 36 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Medulloblastoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Poor accrual
Phase II Malignant Pleural Mesothelioma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
lack of scientific relevance (change in the treatment landscape) and poor recruitment
Phase II Locally Advanced Head and Neck Squamous Cell Carcinoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
discontinuation of all ongoing studies involving xevinapant
Phase II TNBC - Triple-Negative Breast Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
Withdrawn interest from grant provider
Phase III Advanced Soft-tissue Sarcoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
Withdrawal grant provider
Phase II Lymphoma, T-Cell, Cutaneous trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: SAFETY.
Following an urgent safety measure due to toxicity recruitment has been closed prematurely.
Phase II Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
After an extensive assessment of the study feasibility, it was decided to discontinue the clinical trial due to poor recruitment.
Phase II First Progression of MGMT Promoter-methylated Glioblastoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Amgen withdrew interest in providing further financial support
Phase II Inoperable œsophageal Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Poor accrual
Phase II Platinum-Sensitive Biliary Tract Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Company decision
Phase III Low-grade Glioma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Poorly recruiting
Phase II Squamous Non-small Cell Lung Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
Interest withdrawn
Phase II Sarcoma, Soft Tissue trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
Exceed of pre-specified number of failures in the experimental arm
Phase II Lymphoma, T-Cell, Cutaneous trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Lack of feasibility
Phase III Squamous Cell Head and Neck Carcinoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
Company withdrew interest
Phase III Hodgkin Lymphoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Study closed due to lack of recruitment
Phase II Bone Giant Cell Tumor trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Poor accrual
Phase III Sarcoma, Soft Tissue trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Poor accrual
Phase III Prostate Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Extended study timelines and additional budget could no longer be supported.
Phase III Small Intestinal NET trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Company decision
Phase II Esophageal Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Company decision
Phase II Lung Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
poorly recruiting
Phase II Lung Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: SAFETY.
based on IDMC decision
Phase III Lymphoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
recruitment prematurely halted following company's decision to stop financial support to the study
Phase III Lymphoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
poor accrual
Phase II Head and Neck Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: SAFETY.
Recruitment was suspended prematurely for safety concerns and closed after IDMC review
Phase II Esophagogastric Adenocarcinoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Colorectal Cancer Metastatic trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Endometrial Neoplasms trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
supporting company (Eisai) withdrew their interest
Phase II Adenocarcinoma of the Gastroesophageal Junction trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
company withdrew interest
Phase II Colorectal Cancer Metastatic trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Low or poor accrual
Phase II Colorectal Cancer Metastatic trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
poor accrual
Phase II Prostate Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
Pharmaceutical company has terminated orteronel (TAK-700) development for Prostate Cancer
Phase II Uterine Cervical Neoplasms trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
company (Inovio) is no longer able to support the study
Phase II Non Small Cell Lung Cancer trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OPERATIONAL.
Study never started
Phase III Lymphoma trial by European Organisation for Research and Treatment of Cancer - EORTC. Stop reason: OTHER/UNKNOWN.
Company withdrew interest